Paratek Pharmaceuticals, Inc. (PRTK) Seems To Be Turning Some Investors Off

Paratek Pharmaceuticals, Inc. (PRTK) has seen some recent activity in the marketplace and its common shares finished trading at $4.7800 yesterday. Traders are starting to take interest of PRTK as the common shares traded as high as $4.9800 and as low as $4.6200 in the previous trading session.

Paratek Pharmaceuticals, Inc. (PRTK) average trading volume is 617.02K. However, in the previous trading session Paratek Pharmaceuticals, Inc. (PRTK) exchanged 483,918 shares. The 1st support level on PRTK is $4.68 and the 1st upside resistance level on PRTK is $6.69. PRTK 50day moving average is $5.4961 and PRTK 200 day moving average is $4.8286.

Paratek Pharmaceuticals, Inc. (PRTK) most current performance has been indicated by the recent movement in PRTK common shares. PRTK has performed -12.93% over the past 4 weeks, PRTK has performed 7.17% over the past 3 months and PRTK has shown 54.69% over the past 365 days. Paratek Pharmaceuticals, Inc. (PRTK) has a 12 month range of $2.5000 to $6.7200. Paratek Pharmaceuticals, Inc. (PRTK) is trading 91.20% from its 12 month low and -28.87% from its 12 month high. Paratek Pharmaceuticals, Inc. (PRTK) is displaying a 9.16% short float displaying the quantity short in the float.

PRTK has 43.63M shares outstanding and 41.32M shares in the float. Paratek Pharmaceuticals, Inc. (PRTK) currently has a market cap of $224.42M and income of -110.70M. The EPS next quarter for PRTK is -0.61 and anticipated EPS next year is 53.90%. The market cap of Paratek Pharmaceuticals, Inc. (PRTK) at $224.42M represents how many Traders own shares of PRTK and is based off the last price ($4.7800) of PRTK and the quantity of shares outstanding (43.63M) with Paratek Pharmaceuticals, Inc. (PRTK).

Paratek Pharmaceuticals, Inc. (PRTK) has aggregate cash (mrq) of 186.82M, aggregate cash per share (mrq) of 4.12, aggregate debt of PRTK stands at 263.96M. Paratek Pharmaceuticals, Inc. (PRTK) operating cash flow (ttm) is -114.35M, PRTK leveraged free cash flow (ttm) is -75.6M.

PRTK is trading -9.50% below (bearish) its SMA20, -8.73% below (bearish) its SMA50 and 7.03% above (bullish) its SMA200.

Related Articles

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Fuwei (NASDAQ: FFHL) Plans To Sell Dornier Production Line

Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) recently declared that it will be closing its Dornier line of production as early as possible. Fuwei...

PPG Industries (NYSE: PPG) Announces Accquisition Of Ennis-Flint

PPG Industries, Inc. (NYSE: PPG) is planning to buy Ennis-Flint in a deal valued at nearly $1.15 billion. The decision to acquire Ennis-Flint will...